CHICAGO HIGHLIGHTS 2024 – GI ROUNDTABLE DISCUSSION: CheckMate 9DW

CHICAGO HIGHLIGHTS 2024 – GI ROUNDTABLE DISCUSSION: CheckMate 9DW

Chicago Highlights 2024 Roundtable Discussions
Icon Chair Speaker

Chair

Dr. Scott Berry

Icon Chair Speaker

Panelists

Dr. Sharlene Gill
Dr. Florian Lordick

Studies/trials discussed:

  • A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma (CheckMate 9DW)
  • Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
  • Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
Tagged